sexta-feira, 13 de novembro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 27, 2026

Tech stocks today: President Trump orders US government to stop using Anthropic tech amid Pentagon feud

View original at finance.yahoo.com
Tech stocks today: President Trump orders US government to stop using Anthropic tech amid Pentagon feud The feud between Anthropic and the Department of Defense ratcheted up on Friday after President Trump ordered all government agencies to immediately cease using the artificial intelligence startup's technology…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The global smartphone market, particularly Android manufacturers, faces a significant threat

    80% confidence
  • If Anthropic doesn't cooperate during phase-out, he will use full power of presidency to force compliance with civil and criminal consequences

    80% confidence
  • There will be a six-month phase-down period for agencies like DOD that use Anthropic's products

    80% confidence
  • The federal government will immediately cease all use of Anthropic's technology

    80% confidence
  • Anthropic cannot in good conscience agree to Pentagon's request for unrestricted AI model usage

    80% confidence
  • OpenAI is working on a deal to help resolve the feud between Anthropic and the Department of Defense

    80% confidence
  • Hyperscaler revenue remained the largest customer category at slightly over 50% of Data Center revenue in Q4

    80% confidence
  • DOD has no interest in using AI to conduct mass surveillance of Americans or develop autonomous weapons without human involvement

    80% confidence
  • The assumption that Pentagon will use Anthropic's tools for mass surveillance or autonomous weapons is a fake narrative peddled by leftists in the media

    80% confidence
  • He is confident in hyperscalers' cash flow growing due to agentic AI and enterprise compute demand

    80% confidence
  • Capital expenditures will increase from $15.4 billion in 2025 to at least $30 billion in 2026

    80% confidence
  • What we are witnessing is not a temporary squeeze, but a tsunami-like shock originating in the memory supply chain

    80% confidence
  • Data Center revenue for Q4 was a record $62.3 billion, up 75% year-over-year and 22% sequentially, driven by accelerated computing and AI

    80% confidence
  • This is a simple request that will prevent Anthropic from jeopardizing critical military operations and putting warfighters at risk

    80% confidence
  • Nvidia is ready to push into making CPUs that Intel and AMD are known for

    80% confidence
  • DOD's contract language made virtually no progress on preventing Claude's use for mass surveillance or autonomous weapons

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,995
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,995 factos verificados com a fonte5,577 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Tech stocks today: President Trump orders US government to stop using Anthropic tech amid Pentagon feud — Source | Via News | pt.VIA.NEWS